Clinical Trial Update: Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated whether morning dosing of a new medicine affects sleep at bedtime in adults with insomnia; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Sleep Initiation and Maintenance Disorders, Insomnia | Phase 2 | Status: COMPLETED